Use of calcium channel blockers in hypoxic lung disease

J. R. Michael, S. Selinger, W. Parham, P. Buescher, D. Wong, T. P. Kennedy

Research output: Contribution to journalArticlepeer-review

Abstract

COPD patients who are hypoxic developed pulmonary hypertension primarily because alveolar hypoxia induces muscular hypertrophy of pulmonary arteries. This muscular hypertrophy will regress in animals if they receive continuous oxygen therapy. Since many COPD patients refuse to use oxygen continuously, calcium channel blockers, which inhibit hypoxic pulmonary vasoconstriction, may be effective adjuvant therapy. Nifedipine lowers pulmonary vascular resistance during rest and exercise in hypoxic COPD patients.

Original languageEnglish (US)
Pages (from-to)260S-263S
JournalCHEST
Volume88
Issue number4 SUPPL.
DOIs
StatePublished - 1985

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Use of calcium channel blockers in hypoxic lung disease'. Together they form a unique fingerprint.

Cite this